Abstract
In patients with recurrent malignant glioma, treatment-related myelodysplastic syndrome (t-MDS) and acute leukemia are rare adverse effects because the median survival after relapse is limited. We report a 44-year-old woman with t-MDS (refractory anemia with excess blasts) following treatment of recurrent anaplastic astrocytoma with temozolomide (TMZ). A cytogenetic study showed del (3)(q11.1). MDS was diagnosed 8.4 months after beginning TMZ. The disease rapidly evolved into acute leukemia within 1 month after the onset of MDS, and the patient died 1 month later during induction chemotherapy. The prognosis of t-MDS is generally poor. Considering the increasing use of TMZ, which is regarded as a drug with moderate toxicity, careful follow-up with routine blood testing is vital.
Similar content being viewed by others
References
MF Greaves (1997) ArticleTitleAetiology of acute leukemia Lancet 349 344–349
ET Wong KR Hess MJ Gleason KA Jaeckle AP Kyritsis MD Prados VA Levin WK Yung (1999) Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 17(8) 2572
RE Curtis JD Boice M Stovall L Bernstein RS Greenberg JT Flannery AG Schwartz P Weyer WC Moloney RN Hoover (1992) ArticleTitleRisk of leukemia after chemotherapy and radiation treatment for breast cancer N Engl J Med 326 IssueID26 1745–1751
MH Greene JD Boice TA Strike SuffixJr (1985) ArticleTitleCarmustine as a cause of acute nonlymphocytic leukemia N Engl J Med 313 IssueID9 579
DR Macdonald (2001) ArticleTitleTemozolomide for recurrent high-grade glioma Semin Oncol 28 IssueID4 Suppl 13 3–12
WK Yung (2000) ArticleTitleTemozolomide in malignant gliomas Semin Oncol 27 IssueID3 Suppl 6 27–34
WK Yung RE Albright J Olson R Fredericks K Fink MD Prados M Brada A Spence RJ Hohl W Shapiro M Glantz H Greenberg RG Selker NA Vick R Rampling H Friedman P Phillips J Bruner N Yue D Osoba S Zaknoen VA Levin (2000) ArticleTitleA phase II study of temozolomide vs procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83 IssueID5 588–593
G Robustelli della Cuna P Paoletti G Bernardo R Knerich G Butti Q Cuzzoni (1982) ArticleTitleClinical toxicity of combined modality treatment with nitrosourea derivatives for central nervous system tumors Neurosurgery 11 IssueID3 408–411
J Hildebrand M Malarme J Flament-Durand P Stryckmans (1982) ArticleTitleAcute nonlymphoblastic leukemia in a patient treated for brain tumor Arch Neurol 39 IssueID10 664–665
JY Genot M Krulik M Poisson R Efferterre Particlevan M Renoux AA Audebert C Canuel N Smadja J Debray (1983) ArticleTitleTwo cases of acute leukemia following treatment of malignant glioma Cancer 52 IssueID2 222–226
S Kempin N Sundaresan WB Shapiro Z Arlin (1984) ArticleTitleAcute nonlymphocytic leukemia following treatment of malignant glioma Report of two cases. J Neurosurg 60 IssueID6 1287–1290
J Blatt L Penchansky C Phebus M Horn (1991) ArticleTitleLeukemia in a child with a history of medulloblastoma Pediatric Hematol Oncol 8 IssueID1 77–82
HM Kantarjian MJ Keating RS Walters TL Smith A Cork KB McCredie EJ Freireich (1986) ArticleTitleTherapy-related leukemia and myelodysplastic sundrome: clinical, cytogenetic, and prognostic features J Clin Oncol 4 IssueID12 1748–1757
JD Rowley HM Golomb JW Vardiman (1981) ArticleTitleNonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease Blood 58 IssueID4 759–767
MJ Thirman RA Larrson (1996) ArticleTitleTherapy-related myeloid leukemia Hematol Oncol Clin N Am 10 IssueID2 293–320
WK Yung MD Prados R Yaya-Tur SS Rosenfeld M Brada HS Friedman R Albright J Olson SM Chang AM O’Neill AH Friedman J Bruner N Yue M Dugan S Zaknoen VA Levin (1999) ArticleTitleMulticenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse Temodal Brain Tumor Group J Clin Oncol 17 IssueID9 2762–2771 Occurrence Handle1:CAS:528:DyaK1MXmtlWru7s%3D Occurrence Handle10561351
M Arakawa F Shimizu N Okda (1974) ArticleTitleEffect of 1-(4-amino-2-methyl-pyrimidin-5-yl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride on leukemia L-1210 Jpn J Cancer Res 65 191
M Kazuo M Tomohiko S Masaki H Kiyohiko A Youichi M Yasusada (1996) ArticleTitleTherapy–related chronic myelomonocytic leukemia with bone marrow eosinophilia associated with der (11) t(1;11)(q21;q14) Acta Hematol 96 IssueID4 25–254
N Masami B Shuji T Taizo F Mitsuhiro Y Amane K Hiroko F Yasunobu Y Genji T Jiro (1999) ArticleTitleSecondary myeloid/natural killer cell precursor acute leukemia following essential thrombocythemia Hum Pathol 30 IssueID7 868–871
F Oshita T Tamura A Kojima K Yamada M Fukuda K Nakagawa Y Ohe Y Sasaki K Eguchi T Shinkai et al. (1991) ArticleTitleLate toxicities and complications in three-year survivors of small cell lung cancer Eur J Cancer 27 IssueID4 427–430
T Kageshita N Kuribayashi T Ono (2000) ArticleTitleMyelodysplastic syndrome following treatment of malignant melanoma with vincristine, ACNU, and dacarbazine J Dermatol 27 IssueID3 178–180
MJ Laughlin DS McGaughey JR Crews NJ Chao D Rizzieri M Ross J Gockerman C Cirrincione D Berry L Mills P Defusco S LeGrand WP Peters JJ Vredenburgh (1998) ArticleTitleSecondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant J Clin Oncol 16 IssueID3 1008–1012
MJ Bent Particlevan den O Chinot W Boogerd J Bravo Marques MJ Taphoorn JM Kros CC Rijt Particlevan der CJ Vecht N Beule ParticleDe B Baron (2003) ArticleTitleSecond-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972 Ann Oncol 14 IssueID4 599–602
R Stupp PY Dietrich S Ostermann Kraljevic A Pica I Maillard P Maeder R Meuli R Janzer G Pizzolato R Miralbell F Porchet L Regli N Tribolet Particlede RO Mirimanoff S Leyvraz (2002) ArticleTitlePromising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide J Clin Oncol 20 IssueID5 1375–1382 Occurrence Handle10.1200/JCO.20.5.1375 Occurrence Handle1:CAS:528:DC%2BD38XisVWmu7s%3D Occurrence Handle11870182
JD Boice MH Greene JY Killen SuffixJr SS Ellenberg JF Fraumeni SuffixJr RJ Keehn E McFadden TT Chen D Stablein (1986) ArticleTitleLeukemia after adjuvant chemotherapy with semustine (methyl-CCNU)–evidence of a dose-response effect N Engl J Med 314 IssueID2 119–120
S Devereux TG Selassie G Vaughan Hudson B Vaughan Hudson DC Linch (1990) ArticleTitleLeukaemia complicating treatment for Hodgkin’s disease: the experience of the British National Lymphoma Investigation Br Med J 301 IssueID6760 1077–1080
JR Perry MT Brown JP Gockerman (1998) ArticleTitleAcute leukemia following treatment of malignant glioma J Neurooncol 40 IssueID1 39–46 Occurrence Handle10.1023/A:1006175831785 Occurrence Handle1:STN:280:DyaK1M%2FovFGrsg%3D%3D Occurrence Handle9874184
B Johansson F Mertens F Mitelman (1996) ArticleTitlePrimary vs secondary neoplasia associated chromosomal abnormalities–balanced rearrangements vs. genomic imbalances? Gene Chromosome Cancer 16 IssueID3 155–163
C Lengauer KW Kinzler B Vogelstein (1998) ArticleTitleGenetic instabilities in human cancers Nature 396 IssueID6712 643–649 Occurrence Handle10.1038/25292 Occurrence Handle1:CAS:528:DyaK1MXisVWqsQ%3D%3D
T Yamaguchi J Toguchida T Yamamuro Y Kotoura N Takada N Kawaguchi Y Kaneko Y Nakanura MS Sasaki K Ishizaki (1992) ArticleTitleAllelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q Cancer Res 52 2419–2423
E Edstrom E Mahlamaki B Nord M Kjellman R Karhu A Hoog N Goncharov BT Teh M Backdahl C Larsson (2000) ArticleTitleComparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology Am J Pathol 156 651–659
F Tschentscher G Prescher DE Horsman VA White H Rieder G Anastassiou H Schilling N Bornfeld KU Bartz-Schmidt B Horsthemke DR Lohmann M Zeschnigk (2001) ArticleTitlePartial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma Cancer Res 61 IssueID8 3439–3442
AI Neugut E Robinson J Nieves T Murray WY Tsai (1990) ArticleTitlePoor survival of treatment-related acute nonlymphocytic leukemia JAMA 264 IssueID8 1006–1008
C Strupp U Germing M Aivado E Misgeld R Haas N Gattermann (2002) ArticleTitleThalidomide for the treatment of patients with myelodysplastic syndromes Leukemia 16 IssueID1 1–6
A Badros C Morris M Zangari B Barlogie G Tricot (2002) ArticleTitleThalidomide paradoxical effect on concomitant multiple myeloma and myelodysplasia Leukemia Lymphoma 43 IssueID6 1267–1271
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Su, YW., Chang, MC., Chiang, MF. et al. Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma. J Neurooncol 71, 315–318 (2005). https://doi.org/10.1007/s11060-004-2028-0
Issue date:
DOI: https://doi.org/10.1007/s11060-004-2028-0